Status:

COMPLETED

Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED)

Lead Sponsor:

Merck Sharp & Dohme LLC

Conditions:

Glaucoma

Ocular Hypertension

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This study is comparing 2 medications for glaucoma and how effective they are at controlling glaucoma over the course of an entire day.

Eligibility Criteria

Inclusion

  • Patients with glaucoma or ocular hypertension

Exclusion

  • Other eye conditions
  • Poor vision
  • Recent eye surgery
  • Use of contact lenses
  • Nursing or pregnant women
  • Use of some other selected medications
  • Drug or alcohol abuse
  • Asthma
  • Slow heart beat
  • Allergy or previous reaction to study drugs

Key Trial Info

Start Date :

April 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2006

Estimated Enrollment :

330 Patients enrolled

Trial Details

Trial ID

NCT00108017

Start Date

April 1 2005

End Date

July 1 2006

Last Update

May 13 2015

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED) | DecenTrialz